# The Real Life Topical Field Treatment of Actinic Keratosis Study

> **NCT02362152** · — · COMPLETED · sponsor: **LEO Pharma** · enrollment: 1168 (actual)

## Conditions studied

- Actinic Keratosis

## Interventions

- **DRUG:** Ingenol mebutate
- **DRUG:** 5-fluorouracil
- **DRUG:** Imiquimod
- **DRUG:** Diclofenac

## Key facts

- **NCT ID:** NCT02362152
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 1168 (ACTUAL)
- **Last updated:** 2019-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02362152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02362152, "The Real Life Topical Field Treatment of Actinic Keratosis Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02362152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*